文献速递免疫规划卫生政策与健康促进

老年人的疫苗偏好与接种接受度

Vaccine preferences and acceptance of older adults.
PubMed 文献 · Vaccine · 2017-04-12

该研究采用离散选择实验与混合多项logit模型,分析荷兰老年人对肺炎球菌、带状疱疹、百日咳和流感疫苗的偏好与接受度。结果显示,高死亡风险、高易感性和高疫苗有效性是接种接受度的重要相关因素,肺炎球菌疫苗的潜在接种率最高。50-65岁人群的潜在接种率低于65岁及以上人群。

要点

  • 高死亡风险、高易感性和高疫苗有效性是老年人接种接受度的重要相关因素。
  • 肺炎球菌疫苗潜在接种率68.1%,带状疱疹58.1%,百日咳53.9%,流感54.3%。
  • 50-65岁人群潜在接种率低于65岁及以上人群,需特别关注前者的接种率提升。

核心结论

  • 研究结果表明,在四种疫苗中,老年人最可能接受肺炎球菌疫苗。
  • 伴随新疫苗实施的信息提供需针对个体和相应疫苗进行定制。
  • 需特别关注确保50-65岁人群的高接种率。

研究设计与样本

  • 在荷兰老年人中开展离散选择实验,使用混合多项logit统计模型分析选择数据。
  • 研究涉及肺炎球菌疾病、带状疱疹、百日咳和流感疫苗接种。

主要发现

  • 与疫苗接种接受度相关的重要因素包括:感染性疾病的高死亡风险、感染性疾病的高易感性以及高疫苗有效性。
  • 影响疫苗偏好的个人因素包括年龄、2013年流感疫苗接种情况和自评健康评分。
  • 老年人潜在接种率估计为:肺炎球菌疫苗68.1%,带状疱疹疫苗58.1%,百日咳疫苗53.9%,流感疫苗54.3%。
  • 50-65岁人群潜在接种率估计为:肺炎球菌疫苗58.1%,带状疱疹疫苗49.5%,百日咳疫苗43.9%,流感疫苗42.2%。
  • 65岁及以上人群潜在接种率估计为:肺炎球菌疫苗76.2%,带状疱疹疫苗67.5%,百日咳疫苗57.5%,流感疫苗65.5%。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Expanding vaccination programs for the older population might be important as older adults are becoming a larger proportion of the general population. The aim of this study is to determine the relative importance of vaccine and disease specific characteristics and acceptance for Dutch older adults, including pneumococcal disease, herpes zoster, pertussis vaccination, and influenza vaccination. METHODS: A discrete choice experiment was conducted to generate choice data that was analyzed using a mixed multinomial logit statistical model. RESULTS: Important factors that were associated with vaccination acceptance in older adults are high mortality risk of the infectious disease, high susceptibility of getting the infectious disease, and high vaccine effectiveness. Age, influenza vaccination in 2013 and self-perceived health score were identified as personal factors that affect vaccine preference. Potential vaccination rates of older adults were estimated at 68.1% for pneumococcal vaccination, 58.1% for herpes zoster vaccination, 53.9% for pertussis vaccination and 54.3% for influenza vaccination. For persons aged 50-65, potential vaccination rates were estimated at 58.1% for pneumococcal vaccination, 49.5% for herpes zoster vaccination, 43.9% for pertussis vaccination and 42.2% for influenza vaccination. For persons aged 65 and older, these were respectively 76.2%, 67.5%, 57.5% and 65.5%. DISCUSSION: Our results suggest that older adults are most likely to accept pneumococcal vaccination of the four vaccines. Information provision accompanied with the implementation of a new vaccine has to be tailored for the individual and the vaccine it concerns. Special attention is needed to ensure high uptake among persons aged 50-65years.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Eilers R, de Melker HE, Veldwijk J, et al. Vaccine preferences and acceptance of older adults. Vaccine. 2017. PMID: 28412075. doi:10.1016/j.vaccine.2017.04.014

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。